Abstract The Barcelona Clinic Liver Cancer (BCLC) system is the most commonly used
staging system for hepatocellular carcinoma (HCC) in Western countries. BCLC aims to …

Radiopharmaceutical therapy (RPT) is defined as the delivery of radioactive atoms to tumor-
associated targets. In RPT, imaging is built into the mode of treatment since the …

Background All randomised phase 3 studies of selective internal radiation therapy for
advanced hepatocellular carcinoma published to date have reported negative results …

Background Transarterial chemoembolization (TACE) is the recommended treatment for
intermediate hepatocellular carcinoma (HCC) according to the Barcelona Clinic Liver …

Primary liver tumours (ie hepatocellular carcinoma (HCC) or intrahepatic
cholangiocarcinoma (ICC)) are among the most frequent cancers worldwide. However, only …

Purpose A multidisciplinary expert panel convened to formulate state-of-the-art
recommendations for optimisation of selective internal radiation therapy (SIRT) with yttrium …

Purpose: Synergistic effect of radiotherapy and immunotherapy for the treatment of
hepatocellular carcinoma (HCC) has been reported. This phase I/IIa pilot trial evaluated …

Original research: Nivolumab after selective internal radiation therapy for the treatment of
hepatocellular carcinoma: a phase 2, single-arm study - PMC Back to Top Skip to main content …

Purpose To address the lack of prospective data on the real-life clinical application of trans-
arterial radioembolization (TARE) in Europe, the Cardiovascular and Interventional …

Simple Summary Hepatocellular carcinoma is the fourth leading cause of cancer-related
mortality worldwide and a major health problem. Overall survival is poor, with a five-year …